
|Videos|July 4, 2021
Dr. Ramasamy discusses investigational oral testosterone treatment
Author(s)Urology Times staff
Ranjith Ramasamy, MD, comments on SOV2012-F1 (Kyzatrex), an oral testosterone undecanoate soft gelatin capsule.
Advertisement
In this video, Ranjith Ramasamy, MD, discusses SOV2012-F1 (Kyzatrex), an oral testosterone undecanoate soft gelatin capsule for which the FDA recently accepted a new drug application. Ramasamy is an associate professor of urology and director of male reproductive medicine and surgery at the University of Miami Miller School of Medicine.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
John Sfakianos, MD, discusses evolving management of recurrent LG-IR-NMIBC
2
AI-generated profiles impersonate female urologists to market ED products online
3
App-based intervention aims to increase PSA screening among Black men
4
Interpreting real-world evidence in ARPI treatment decisions, with Martin Schoen, MD, PhD
5






